Status:
UNKNOWN
Efficacy of Two Therapeutic Exercise Modalities for Patients With Persistent COVID
Lead Sponsor:
Facultat de ciencies de la Salut Universitat Ramon Llull
Conditions:
Persistent COVID-19
Eligibility:
All Genders
18-60 years
Phase:
NA
Brief Summary
Symptoms of long-standing sequelae and complications of COVID-19, termed Long COVID19 or persistent COVID, have been reported worldwide. However, the etiology underlying the prolonged or fluctuating s...
Detailed Description
Objective: To evaluate the effects on the perception of fatigue in patients with persistent COVID, who undergo a supervised and directed therapeutic exercise program in a health center compared to a h...
Eligibility Criteria
Inclusion
- Adult patients diagnosed with LongCOVID19 or persistent COVID19.
- Agree to participate and sign the informed consent form.
Exclusion
- Patients with comorbidities associated with having fatigue (e.g. cancer survivors, severe cardiovascular or respiratory disease prior to persistent COVID).
- Taking medication of drugs that may interfere with the perception of fatigue.
- Patients with mental disorders or cognitive impairment prior to persistent COVID.
- Patients who regularly practice intense sports (\>4h/week).
- Any illness that may condition understanding and compliance with the study.
Key Trial Info
Start Date :
June 1 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 1 2025
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT06142240
Start Date
June 1 2023
End Date
September 1 2025
Last Update
November 21 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CSSV-Rif
Barcelona, Vilafranca Del Penedés, Spain, 08720